RT @HealthLawAdamH: And yet again, #rifampin for #tuberculosis is back in Tier 3 shortage ("Tier 3 shortages are those that have the greate…
And yet again, #rifampin for #tuberculosis is back in Tier 3 shortage ("Tier 3 shortages are those that have the greatest potential impact on Canada's drug supply and health care system"). This keeps happening. Time for systemic change, not short-term fixe
It appears that notably more people read our letter @CMAJ this October than any other month in the past year. Hopefully a metric foreshadowing a burst of new attention to the underlying issue of #tuberculosis drug shortages in Canada? #TB🇨🇦💊😷#rifampin htt
RT @HealthLawAdamH: Underscoring the gong show of #tuberculosis treatment & #AccessToMedicines in Canada: As an alternative for latent #TB…
RT @HealthLawAdamH: Underscoring the gong show of #tuberculosis treatment & #AccessToMedicines in Canada: As an alternative for latent #TB…
Underscoring the gong show of #tuberculosis treatment & #AccessToMedicines in Canada: As an alternative for latent #TB during critical #rifampin shortage, Gov't of Canada suggests #rifapentine, a drug STILL NOT AUTHORIZED IN CANADA. 🇨🇦💊😷 Both drugs ar
RT @HealthLawAdamH: Right now there is an actual shortage of #rifampin, a crucial drug for #tuberculosis, across Canada. Might as well just…
RT @HealthLawAdamH: Right now there is an actual shortage of #rifampin, a crucial drug for #tuberculosis, across Canada. Might as well just…
Right now there is an actual shortage of #rifampin, a crucial drug for #tuberculosis, across Canada. Might as well just photocopy & resubmit our recent letter @CMAJ "Responsible use of rifampin in Canada is threatened by irresponsible shortages" https:
⏳2019⌛️“Responsible use of Rifampin in Canada is threatened by irresponsible shortages” (with @rdcooper57 & Faiz Ahmad Khan) in Canadian Medical Association Journal @CMAJ https://t.co/6VrPVjsoFs
We wrote earlier this year about a #rifampin shortage for #tuberculosis in Canada. Now we're facing a looming shortage of #ethambutol. These are extremely basic drugs, @GovCanHealth @CDNMinHealth. This is not ok. 😷💊🇨🇦 https://t.co/CWIWfh0Ylh
RT @OttawaHealthLaw: In CMAJ by @HealthLawAdamH, Ryan Cooper and Faiz Ahmad Khan: Responsible use of rifampin in Canada is threatened by ir…
RT @OttawaHealthLaw: In CMAJ by @HealthLawAdamH, Ryan Cooper and Faiz Ahmad Khan: Responsible use of rifampin in Canada is threatened by ir…
In CMAJ by @HealthLawAdamH, Ryan Cooper and Faiz Ahmad Khan: Responsible use of rifampin in Canada is threatened by irresponsible shortages https://t.co/ajHYZXKu4O
RT @UofA_ID: New letter in @CMAJ by @HealthLawAdamH, our TB expert Dr Ryan Cooper @rdcooper57 & Dr. Faiz Ahmad Khan Responsible use of rif…
RT @UofA_ID: New letter in @CMAJ by @HealthLawAdamH, our TB expert Dr Ryan Cooper @rdcooper57 & Dr. Faiz Ahmad Khan Responsible use of rif…
New letter in @CMAJ by @HealthLawAdamH, our TB expert Dr Ryan Cooper @rdcooper57 & Dr. Faiz Ahmad Khan Responsible use of rifampin in Canada is threatened by irresponsible shortages https://t.co/mOlmRPh9uw
RT @OttawaHealthLaw: CMAJ: Responsible use of rifampin in Canada is threatened by irresponsible shortages: @HealthLawAdamH, Ryan Cooper, Fa…
RT @OttawaHealthLaw: CMAJ: Responsible use of rifampin in Canada is threatened by irresponsible shortages: @HealthLawAdamH, Ryan Cooper, Fa…
CMAJ: Responsible use of rifampin in Canada is threatened by irresponsible shortages: @HealthLawAdamH, Ryan Cooper, Faiz Ahmad Khan. https://t.co/ajHYZXKu4O
RT @HealthLawAdamH: Online since July, my letter with @rdcooper57 & @McGill_TB's Faiz Ahmad Khan is now officially in print in @CMAJ: "Resp…
RT @HealthLawAdamH: Online since July, my letter with @rdcooper57 & @McGill_TB's Faiz Ahmad Khan is now officially in print in @CMAJ: "Resp…
Online since July, my letter with @rdcooper57 & @McGill_TB's Faiz Ahmad Khan is now officially in print in @CMAJ: "Responsible use of Rifampin in Canada is threatened by irresponsible shortages" #tuberculosis #EssentialMedicines #AccessToMedicines 💊😷🇨🇦